CClinicalTrials.gg
CompletedNCT05957705Updated Jul 24, 2023

Maxillary Sinus Augmentation With Xenogeneic Bone Graft Associated or Not With Fibrin Rich in Platelets and Leukocytes Produced by Horizontal Centrifugation: A Randomized Clinical Trial.

An interventional study of Maxilar Sinus augmentation and Dental implant placement using guided surgery in Platelet-rich Fibrin, Sinus Floor Augmentation and Cone-beam Computed Tomography, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 35 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-07-24.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Mar 2021, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Randomized
Ages
35 Years to 75 Years
Sex
All
01

Study summary

The objective of study is to evaluate the influence of the use of Platelet Rich Fibrin (PRF) from the patient's produced by a new horizontal centrifugation protocol associated with particulate xenogenous bone graft in the rehabilitation of atrophic maxillary sinus for early osseointegrated implants plancement. In a split-mouth model, twelve patients in need of rehabilitation with at least two bilateral implants in the regions of atrophic maxillary sinus will simultaneously undergo bone reconstruction using deproteinized particulate xenogenous bone (Bio-Oss Small®; Geistlich AG, Wolhusen , Switzerland). Randomly, one of the surgical sites of each patient will be reconstructed using the associated technique of solid PRF + Liquid PRF with the xenogen material, where at the end of the grafting procedure, both sites will be protected by a collagen membrane (Bio-Gide® Compressed; Geistlich AG, Wolhusen, Switzerland) positioned over the surgical access of the maxillary sinus. During the research, cone-beam computed tomography scans will be performed preoperatively, immediately after surgical procedure, 3 months after maxillary sinus reconstruction, after immediate implants placement and 12 months after functional load of the implants for comparative volume measurement of tissue gain and the maintenance of the grafted tissue. During the implant surgery, bilateral biopsies will be collected after 4 months of the regenerative surgical procedure during the early dental implants surgery by virtually guided surgery. The stability of the implants will be measured by means of resonance frequency analysis (ISQ) after the immediate postoperative period and 6 postoperative months as the clinical success rates of the implants after 12 months with functional load. The tissue samples will be used for histological, histomorphometric, immunohistochemistry and microtomographic analysis. All data obtained will be statistically analyzed.

02

Conditions studied

  • Platelet-rich Fibrin
  • Sinus Floor Augmentation
  • Cone-beam Computed Tomography
  • Dental Implants
  • Bone Substitutes
  • Maxillary Sinus
  • Atrophic Maxilla

Browse trials for

03

In context

Atrophy

828 studies on the registry are indexed under Atrophy; 122 are open to participants now.

This study's enrollment of 13 is below the median of 34 across 603 interventional studies indexed under Atrophy.

Browse Atrophy studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • need of at least one dental implant in atrophic maxillary sinus region;
  • insufficient amount of vertical bone remnant for the dental implants surgery (maximum of 4mm);
  • sufficient horizontal bone thickness for dental implants rehabilitation;
  • present edentulism in the area to be treated for at least 6 months;
  • similar pattern of pneumatization of the maxillary sinuses.

Exclusion criteria

Exclusion Criteria:

  • any contraindication for the installation of dental implants;
  • need of horizontal bone augmentation;
  • pacientes with inflammatory or autoimmune disease in the oral cavity;
  • use of immunosuppressants, corticosteroids or bisphosphonates for medical needs;
  • pacientes with history of malignancy in the last 5 years;
  • smoking patients or patients reporting excessive alcohol consumption;
  • decompensated systemic condition, uncontrolled periodontal disease, insulin-dependent diabetic patients, patients with blood-related diseases and patients who need oral rehabilitation in the lower arch;
  • It is also noteworthy that patients with a history of reconstructive bone therapies in the maxillary sinus region or with a history of oroantral communication will be excluded from this research.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
13 participants (actual)

Study arms

  • Active comparator
    Bilateral Sinus Augmentation

    Split-mouth bilateral sinus augmentation of xenogeneic bone graft associated or not with platelet-rich fibrin produced by horizontal centrifugation.

    Procedure: Maxilar Sinus augmentation

  • Active comparator
    Early dental implant placement by Guided Surgery

    Procedure: Dental implant placement using guided surgery

  • Active comparator
    Dental implants reopening surgery for implant load

    Procedure: Dental implant placement using guided surgery

Interventions

  • ProcedureMaxilar Sinus augmentation

    The patients will be submitted to bilateral sinus augmentation using two different techniques to provide enough bone tissue for dental implants placement.

    Also known as: Maxilar sinus lift, Maxilary sinus lifting

  • ProcedureDental implant placement using guided surgery

    After 4 months of sinus augmentation, patients will be prepared to receive dental implants for oral rehabilitation. Performed by guided surgery the implants will be placed at the best location for the rehabilitation and at the place were the sinus lighting were performed.

    Also known as: Dental implant, Dental implant surgery, Dental implant guided surgery

06

What researchers measure

Primary outcomes

  1. Micro-CT and Histometric analyses

    After the period of 4 months from sinus reconstructions, during the dental implant placement by guided surgery, bone samples will be collected at the same location of the implants preparation. The collected bone tissue will be prepared and submitted to Micro-CT and histometric analyses.

    Time frame: 4 Months

Secondary outcomes

  1. Dental Implants ISQ measurement

    ISQ will be measured at the moment of implant placement and after 6 months.

    Time frame: 6 months

07

Study locations

1 site
  • School of Dentistry of Ribeirão Preto - USP
    Ribeirão Preto, São Paulo 14040-904, Brazil
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05957705
Lead sponsor
University of Sao Paulo
Responsible party
Michel Reis Messora (Associate professor at the department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirao Preto, University of Sao Paulo-USP, Ribeirao Preto, São Paulo, Brazil, University of Sao Paulo) — Principal investigator
First posted
Jul 24, 2023
Start date
Mar 17, 2021
Primary completion
Apr 30, 2023
Completion
Jul 15, 2023
Last update
Jul 24, 2023

Study contacts

Dr. Michel R Messora, Phd
study chair · Universidade de São Paulo - FORP-USP
Gabriel GD Reis, Phd Student
principal investigator · Universidade de São Paulo - FOR-USP

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion